305 results on '"Surette, M."'
Search Results
2. A15 LEVERAGING CULTURE-DEPENDENT AND -INDEPENDENT METAGENOMICS TO IDENTIFY ENTEROBACTERIACEAE GENES ASSOCIATED WITH ACTIVE ULCERATIVE COLITIS
3. Epidemiology and impact of methicillin-sensitive Staphylococcus aureus with β-lactam antibiotic inoculum effects in adults with cystic fibrosis
4. Detailed Map of a Cis-Regulatory Input Function
5. Ordering Genes in a Flagella Pathway by Analysis of Expression Kinetics from Living Bacteria
6. A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome
7. A45 FIBER-FREE DIET REDUCES BACTEROIDES ABUNDANCE AND PREVENTS MUCUS DEGRADATION IN MICE COLONIZED WITH MICROBIOTA FROM PATIENTS WITH GENERALIZED ANXIETY DISORDER
8. A33 EFFECTS OF THE NEXT GENERATION PROBIOTIC, AKKERMANSIA MUCINIPHILA, ON INTESTINAL INFLAMMATION AND BARRIER FUNCTION
9. A267 IDENTIFYING ENTEROBACTERIACEAE VIRULENCE GENES ASSOCIATED WITH ACTIVE DISEASE IN ULCERATIVE COLITIS PATIENTS USING CULTURE-DEPENDENT AND -INDEPENDENT APPROACHES
10. A8 MICROBIAL ACTIVATION OF INTESTINAL DENDRITIC CELLS IS CRITICAL FOR THE ESTABLISHMENT OF NORMAL BEHAVIOR
11. ePS3.09 Methicillin-sensitive Staphylococcus aureus (MSSa) with inoculum-related reduced susceptibility to cefazolin (CZ) and piperacillintazobactam (TZP) in persons with cystic fibrosis (pwCF)
12. P122 Identification and characterisation of a Liverpool Epidemic Strain (LES) isolate of Pseudomonas aeruginosa, first collected in 1986 in Calgary, Canada
13. A229 GUT MICROBIOTA PROFILES, DIET AND SHORT-CHAIN FATTY ACIDS AS PREDICTORS OF GENERALIZED ANXIETY DISORDER
14. A46 BIOGEOGRAPHIC VARIATION AND FUNCTIONAL PATHWAYS OF THE GUT MICROBIOTA IN CELIAC DISEASE
15. A6 MECHANISMS UNDERLYING GUT DYSFUNCTION FOLLOWING C. DIFFICILE INFECTION AND IMPLICATIONS FOR TREATMENT
16. Histone deacetylase activity and recurrent bacterial bronchitis in severe eosinophilic asthma
17. Pyrosequencing reveals the complex polymicrobial nature of invasive pyogenic infections: microbial constituents of empyema, liver abscess, and intracerebral abscess
18. Microbiota and host determinants of behavioural phenotype in maternally separated mice
19. Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients A Randomized Clinical Trial
20. O10.5 Repeated, low dose Chlamydia infections trigger aberrant immune responses and enhanced tissue pathology
21. The Wavelet-Based Cluster Analysis for Temporal Gene Expression Data
22. Disruption of autophagy by increased 5-HT alters gut microbiota and enhances susceptibility to experimental colitis and Crohn's disease.
23. Salmonella produces an O-antigen capsule regulated by AgfD and important for environmental persistence
24. A51 ENTERIC PARASITE INFECTION-INDUCED ALTERATION OF THE GUT MICROBIOTA REGULATES INTESTINAL GOBLET CELL BIOLOGY AND MUCIN PRODUCTION VIA TLR2 SIGNALING
25. A29 NOVEL FECAL BIOMARKERS THAT PRECEDE CLINICAL DIAGNOSIS OF ULCERATIVE COLITIS
26. A39 CULTURE-ENRICHED METAGENOMICS REVEALED MICROBIAL ENGRAFTMENT FOLLOWING FMT IN PATIENTS WITH ULCERATIVE COLITIS
27. Transfer of IBS phenotype to GERM-free mice through microbiota transplantation: 001
28. MECHANISMS OF ANTIMICROBIAL RESISTANCE IN CYSTIC FIBROSIS AIRWAY ISOLATES OF THE STREPTOCOCCUS MILLERI GROUP: 323
29. EXPLORING THE STREPTOCOCCUS ANTIBIOTIC RESISTOME IN ADULT CYSTIC FIBROSIS PATIENTS: 308
30. Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome
31. The gut microbiome and inflammation in obsessive‐compulsive disorder patients compared to age‐ and sex‐matched controls: a pilot study
32. A50 TRANSFER OF DEPRESSIVE-LIKE PHENOTYPE TO GNOTOBIOTIC MICE DEPENDS ON MICROBIAL FEATURES SPECIFIC TO INDIVIDUAL PATIENTS
33. A45 INFLAMMATION AND INTESTINAL PERMEABILITY IN PEDIATRIC SHORT BOWEL SYNDROME
34. A219 PROTECTIVE EFFECTS OF AKKERMANSIA MUCINIPHILA ON INTESTINAL BARRIER FUNCTION AND INFLAMMATION
35. A261 MICROBIOTA PROFILES OF PATIENTS WITH MENTAL DISODERS DIFFER FROM THOSE OF HEALTHY CONTROLS
36. THE GENUS GEMELLA: COMMENSALS OR PATHOGENS IN CYSTIC FIBROSIS?: 432
37. CARRIAGE OF THE STREPTOCOCCUS MILLERI GROUP IN ADULT CYSTIC FIBROSIS PATIENTS: 431
38. TRANSPOSON MUTAGENESIS OF STREPTOCOCCUS INTERMEDIUS REVEALS β-HEMOLYTIC ACTIVITY: 430
39. PSEUDOMONAS AERUGINOSA POPULATION DYNAMICS AND ADAPTATION IN CYSTIC FIBROSIS: 429
40. STREPTOCOCCUS MILLERI ENDOBRONCHIAL COLONIZATION IS ASSOCIATED WITH AN INCREASED RATE OF PULMONARY DISEASE PROGRESSION IN CYSTIC FIBROSIS: 386
41. MEASUREMENT OF BACTERIAL COMMUNITY DYNAMICS DURING PULMONARY EXACERBATION BY QUANTITATIVE CULTURE AND TERMINAL RESTRICTION FRAGMENT LENGTH POLYMORPHISM (T-RFLP) ANALYSIS: 346⋆
42. An efficient system for markerless gene replacement applicable in a wide variety of enterobacterial species
43. STREPTOCOCCUS MILLERI - AN UNDERESTIMATED PATHOGEN IN CYSTIC FIBROSIS (CF)?: 300⋆
44. Dietary arachidonic and linoleic acids: Comparative effects on tissue lipids
45. P375 Feasibility of the first paediatric randomised controlled pilot trial of faecal microbiota transplant for ulcerative colitis
46. P416 Results of the first paediatric randomised controlled trial of faecal microbiota transplant for ulcerative colitis
47. Clinical Outcomes Associated With Escherichia coli Infections in Adults With Cystic Fibrosis: A Cohort Study
48. A4 INVESTIGATING MICROBIAL ENGRAFTMENT VIA A COMPREHENSIVE CULTURE-ENRICHED AND CULTURE-INDEPENDENT METAGENOMICS IN PATIENTS WITH ULCERATIVE COLITIS
49. A32 THE ROLE OF GUT MICROBIOTA AND TRACE AMINES IN A MURINE MODEL OF GENERALIZED ANXIETY DISORDER
50. Robustness in bacterial chemotaxis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.